Show simple item record

dc.contributor.authorO'BRIEN, FERGALen
dc.contributor.authorDUFFY, GARRYen
dc.date.accessioned2012-06-27T11:43:13Z
dc.date.available2012-06-27T11:43:13Z
dc.date.issued2012en
dc.date.submitted2012en
dc.identifier.citationErica G. Tierney, Garry P. Duffy, Alan J. Hibbitts, Sally-Ann Cryan, Fergal J. O'Brien, The Development of Non-Viral Gene-Activated Matrices for Bone Regeneration Using Polyethyleneimine (PEI) and Collagen-Based Scaffolds, Journal of Controlled Release, 2012en
dc.identifier.otherYen
dc.descriptionIN_PRESSen
dc.description.abstractThe healing potential of scaffolds for tissue engineering can be enhanced by combining them with genes to produce gene-activated matrices (GAMs) for tissue regeneration. We examined the potential of using polyethyleneimine (PEI) as a vector for transfection of mesenchymal stem cells (MSCs) in monolayer culture and in 3D collagen-based GAMs. PEI-pDNA polyplexes were fabricated at a range of N/P ratios and their optimal transfection parameters (N/P 7 ratio, 2 ?g dose) and transfection efficiencies (45 ? 3%) determined in monolayer culture. The polyplexes were then loaded onto collagen, collagen-glycosaminoglycan and collagen-nanohydroxyapatite scaffolds where gene expression was observed up to 21 days with a polyplex dose as low as 2 ?g. Transient expression profiles indicated that the GAMs act as a polyplex depot system whereby infiltrating cells become transfected over time as they migrate throughout the scaffold. The collagen-nHa GAM exhibited the most prolonged and elevated levels of transgene expression. This research has thus demonstrated that PEI is a highly efficient pDNA transfection agent for both MSC monolayer cultures and in the 3D GAM environment. By combining therapeutic gene therapy with highly engineered scaffolds, it is proposed that these GAMs might have immense capability to promote tissue regeneration.en
dc.description.sponsorshipThis study was funded by European Research Council (ERC grant agreement n? 239685) under the EU Seventh Framework Programme (FP7/2007-2013) and a SFI President of Ireland Young Researcher Award, (04/Yl1/B531). Collagen materials were provided by Integra Life Sciences, Inc through a Material Transfer Agreement.en
dc.language.isoenen
dc.relation.ispartofseriesJournal of Controlled Releaseen
dc.rightsYen
dc.subjectBioengineeringen
dc.subjectscaffoldsen
dc.titleThe Development of Non-Viral Gene-Activated Matrices for Bone Regeneration Using Polyethyleneimine (PEI) and Collagen-Based Scaffoldsen
dc.typeJournal Articleen
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/fobrienen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/gaduffyen
dc.identifier.rssinternalid76060en
dc.relation.ecprojectidinfo:eu-repo/grantAgreement/EC/FP7/2007-2013
dc.relation.ecprojectidinfo:eu-repo/grantAgreement/EC/FP7/04/Yl1/B531
dc.subject.TCDThemeNext Generation Medical Devicesen
dc.identifier.rssurihttp://dx.doi.org/10.1016/j.jconrel.2011.11.026en
dc.contributor.sponsorEuropean Research Council (ERC)en
dc.contributor.sponsorGrantNumber239685en
dc.contributor.sponsorEuropean Commissionen
dc.contributor.sponsorGrantNumber2007-2013en
dc.contributor.sponsorScience Foundation Ireland (SFI)en
dc.contributor.sponsorGrantNumber04/Yl1/B531en
dc.identifier.urihttp://hdl.handle.net/2262/64037


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record